Overcoming Resistance in Acute Myeloid Leukemia & Kidney… : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
Susan O’Brien, MD, discusses frontline therapy she recommends for a patient with chronic lymphocytic leukemia with a deletion of 13q, following 4 years of observation…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Technological advances in studying the human microbiome in depth have enabled the identification of microbial signatures associated with health and disease. This confirms the crucial…
Patients with 1 prior line of therapy had improved outcomes on acalabrutinib compared with those who had 2 or more prior lines.
Abstract. Computational methods that simulate tumors mathematically to describe cellular and molecular interactions are emerging as promising tools to simulate the impact of therapy entirely…
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
First-line treatment with ATO plus ATRA improved EFS over chemotherapy plus ATRA in patients with high-risk APL.
The phase III DREAMM-8 trial evaluated belantamab mafodotin, pomalidomide, and dexamethasone (BPd) compared with pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide-exposed patients with RRMM after…
A preclinical study suggests the microbiome may be able to influence the severity of GVHD after bone marrow transplant through donor immune cells that recognize…
Rachel Darwin, Senior Manager, Public Relations NCCN Guidelines for Patients earn Hermes Award for electronic media and Communicator Award for medical print content. NCCN Patient…